ADT1411-MOR202 Biosimilar-Anti-CD38 mAb-Research Grade
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1411 |
Product Name |
ADT1411-MOR202 Biosimilar-Anti-CD38 mAb-Research Grade |
|
Alternate Names anti-cd38, cd38 antibody, anti-cd38 antibody, anti-cd38 monoclonal antibody, anti cd38 antibody, mouse cd38, human cd38, anti-mouse cd38 antibody, recombinant cd38, cd38 antibodies, cd38 recombinant antibody, cd38 blocking antibody |
|
Alias |
MOR202 |
Clonity |
Monoclonal |
Host |
CHO Cells |
Species |
Human |
Target |
CD38 |
Gene ID |
952 |
Isotype |
IgG1-nd |
Size |
1mg, 5mg |
Research Area |
Immunology |
Product Description |
Felzartamab is under investigation in clinical trial NCT04145440 (Trial to Assess Safety and Efficacy of MOR202 in Anti-pla2r + Membranous Nephropathy (Amn)). |
Mechanism of Action |
MOR202 is a monoclonal antibody targeting CD38, a protein involved in immune regulation and cancer progression. |
Metabolism |
MOR202 has a long half-life and distributes throughout the bloodstream and tissues. |
Application |
Elisa, WB |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reactivity |
Human |
|
Reference 1. Ghosh A, et al. Front Immunol, 2023. PMID 37180151
2. Kitada M, et al. Cells, 2023 Feb 12. PMID 36831262
3. Tao Y, et al. Mol Cell Proteomics, 2023 Mar. PMID 36804530
|





